Skip to main content
. 2019 Dec 18;2019:7832752. doi: 10.1155/2019/7832752

Table 1.

Characteristics of buprenorphine prescribers versus nonprescribers.

Characteristics Total n (%) or mean (SD) n = 91 Current prescribers n (%) or mean (SD) n = 60 Nonprescribers n (%) or mean (SD) n = 31 OR (95% CI) p value
Age 52 (12.8)
N = 83
53.9 (13.3)
N = 55
48.1 (11.1)
N = 28
1.04 (0.99–1.08) 0.055
Gender
 Male 64 (70.3) 42 (70.0) 22 (71.0) Reference
 Female 27 (29.7) 18 (30.0) 9 (29.0) 1.05 (0.40–2.71) 0.924
Race/ethnicity
 White 66 (70.3) 48 (80.0) 18 (58.1) Reference
 Non-white 25 (27.5) 12 (20.0) 13 (41.9) 0.35 (0.13–0.90) 0.029
Geographic location
 New York City 52 (57.1) 33 (55.0) 19 (61.3) Reference
 Outside New York City 39 (42.9) 27 (44.5) 12 (38.7) 1.30 (0.54–3.14) 0.566
Years in practice 19 (13)
N = 85
21.6 (13.7)
N = 55
14.5 (10.3)
N = 30
1.05 (1.01–1.10) 0.022
Primary practice specialty
 Psychiatry 44 (48.4) 25 (41.7) 18 (58.1) Reference
 Medicine 35 (38.5) 28 (46.7) 8 (25.8) 2.52 (0.93–6.80) 0.068
 Other 12 (13.2) 7 (11.7) 5 (16.1) 1.01 (0.28–3.69) 0.990
Addiction specialty
 Addiction specialist 17 (18.7) 15 (25.0) 2 (6.5) Reference
 Nonaddiction specialist 74 (81.3) 45 (75.0) 29 (93.5) 0.21 (0.04–0.97) 0.046
Primary practice type
 Solo practice 30 (33.0) 25 (41.7) 5 (16.1) Reference
 Group practice 61 (67.0) 35 (58.3) 26 (83.9) 0.27 (0.09–0.80) 0.018
Academic affiliation
 Yes 51 (56.7) 29 (48.3) 22 (73.3) Reference
 No 39 (43.3)
N = 90
31 (51.7)
N = 60
8 (26.7)
N = 30
2.94 (1.13–7.64) 0.027
Buprenorphine effectiveness
 Heavy/moderate 82 (90.1) 55 (93.2) 27 (93.1) Reference
 Limited/none/DK 6 (6.6)
N = 88
4 (6.8)
N = 59
2 (6.9)
N = 29
0.98 (0.17–5.70) 0.984
How many other buprenorphine providers do you know? 7.03 (8.5)
N = 79
8.60 (10.0)
N = 52
4.0 (2.8)
N = 27
1.19 (1.03–1.38) 0.020

DK: do not know.